Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2025-12-25 @ 3:05 PM
NCT ID:
NCT02864368
Pre Assignment Details:
PEP-CMV vaccine originally was comprised of Component A (a pp65 synthetic long peptide \[SLP\]) and Component B (a neutralizing antibody epitope from human CMV glycoprotein B \[gB\] conjugated to KLH). Component B was removed due to insufficient manufacturing of Component B followed by hypersensitivity reactions in a subset of patients.
Study:
NCT02864368
Study Brief:
Results Section:
NCT02864368